These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25759016)

  • 21. Precision gas therapy using intelligent nanomedicine.
    He Q
    Biomater Sci; 2017 Oct; 5(11):2226-2230. PubMed ID: 28937694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer and the omics revolution.
    Epstein RJ; Lin FP
    Aust Fam Physician; 2017; 46(4):189-193. PubMed ID: 28376570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer genomics guide clinical practice in personalized medicine.
    Lehmann-Che J; Poirot B; Boyer JC; Evrard A
    Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
    Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
    Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
    Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
    An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor DNA-From bench to bedside.
    Lim JSJ; Janku F; Yap TA
    Curr Probl Cancer; 2017; 41(3):212-221. PubMed ID: 28416241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.
    Liu X; Wang P; Zhang C; Ma Z
    Oncotarget; 2017 Jul; 8(30):50209-50220. PubMed ID: 28430586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer as a paradigm for precision oncology in solid tumours.
    Schallenberg S; Merkelbach-Bruse S; Buettner R
    Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways towards Precision Medicine in Cancer Management Using Genomic Information.
    Xie J
    J Genet Genomics; 2015 Oct; 42(10):515-516. PubMed ID: 26554905
    [No Abstract]   [Full Text] [Related]  

  • 33. A vision and a prescription for big data-enabled medicine.
    Chaussabel D; Pulendran B
    Nat Immunol; 2015 May; 16(5):435-9. PubMed ID: 25898187
    [No Abstract]   [Full Text] [Related]  

  • 34. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.
    Thanintorn N; Wang J; Ersoy I; Al-Taie Z; Jiang Y; Wang D; Verma M; Joshi T; Hammer R; Xu D; Shin D
    Pac Symp Biocomput; 2016; 21():417-28. PubMed ID: 26776205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
    Maggi E; Montagna C
    Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution and functional divergence of the ERBB receptor family.
    Wu S; Haltom J; Zhao W; Yang J; Zhou Z; Gu X
    Pharmacogenomics; 2021 Jun; 22(8):473-484. PubMed ID: 34036795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.